// App-Quantinova.ai

PO0295 : Hemoglobin Requirements of Clinical Trials Involving Anemia in CKD and Implications on Future Work: A Systematic Literature Review

Researchers

Presenter

  • Farag YoussefMK

Principal Investigators

  • Langford Bryony

  • Yasmeen Najeeda

  • Sawyer LauraM

  • Sanon Myrlene

  • Wang Xinyu

  • Mccormick Linda

  • Michalopoulos EfstathiosN

Medical Centers

  • Akebia Therapeutics Inc Cambridge Massachusetts United States

  • Symmetron Ltd. London United Kingdom

  • Otsuka Pharmaceutical Development and Commercialization Inc. Princeton New Jersey United States

  • Otsuka Pharmaceutical Europe Ltd. Slough United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved